Fluticasone-Salmeterol Drug Combination
"Fluticasone-Salmeterol Drug Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
Descriptor ID |
D000068297
|
MeSH Number(s) |
D02.033.100.291.057.750.500 D02.092.063.291.057.750.500 D02.092.471.683.061.750.500 D04.210.500.054.079.129.114.500 D26.310.438
|
Concept/Terms |
Fluticasone-Salmeterol Drug Combination- Fluticasone-Salmeterol Drug Combination
- Drug Combination, Fluticasone-Salmeterol
- Fluticasone Salmeterol Drug Combination
- Fluticasone - Salmeterol
- Fluticasone Salmeterol
- Fluticasone-Salmeterol Combination
- Combination, Fluticasone-Salmeterol
- Fluticasone Salmeterol Combination
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination- Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
- Fluticasone Propionate-Salmeterol Xinafoate Combination
- Fluticasone Propionate Salmeterol Xinafoate Combination
- Fluticasone Propionate-Salmeterol Drug Combination
- Fluticasone Propionate Salmeterol Drug Combination
- Fluticasone Propionate - Salmeterol Combination
- Fluticasone Propionate Salmeterol Combination
- Fluticasone Propionate-Salmeterol Xinafoate Drug Combination
- Fluticasone Propionate Salmeterol Xinafoate Drug Combination
- Fluticasone Propionate - Salmeterol Xinafoate
- Fluticasone Propionate Salmeterol Xinafoate
- Fluticasone Propionate - Salmeterol
- Fluticasone Propionate Salmeterol
|
Below are MeSH descriptors whose meaning is more general than "Fluticasone-Salmeterol Drug Combination".
Below are MeSH descriptors whose meaning is more specific than "Fluticasone-Salmeterol Drug Combination".
This graph shows the total number of publications written about "Fluticasone-Salmeterol Drug Combination" by people in this website by year, and whether "Fluticasone-Salmeterol Drug Combination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
2017 | 5 | 1 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Fluticasone-Salmeterol Drug Combination" by people in Profiles.
-
Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist. Int J Chron Obstruct Pulmon Dis. 2017; 12:2477-2485.
-
Initiating or changing to a fixed-dose combination of Fluticasone propionate/Formoterol over Fluticasone propionate/Salmeterol: A real-life effectiveness and cost impact evaluation. Respir Med. 2017 08; 129:199-206.
-
Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma. Allergy Asthma Proc. 2017 09 21; 38(5):343-353.
-
Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial. Am J Respir Crit Care Med. 2017 05 01; 195(9):1189-1197.
-
Debate on long-acting ß agonists for asthma: they think it's all over. Lancet Respir Med. 2017 03; 5(3):e14-e15.
-
Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study. Int J Chron Obstruct Pulmon Dis. 2017; 12:339-349.
-
Extrafine beclomethasone/formoterol compared to fluticasone/salmeterol combination therapy in COPD. BMC Pulm Med. 2014 Mar 12; 14:43.
-
Effects of intranasal salmeterol and fluticasone given alone and in combination in persistent allergic rhinitis. Ann Allergy Asthma Immunol. 2012 Jan; 108(1):54-59.